Answers are grounded in this paper and cite their sources.
The relationships between pulmonary hypertension multiple myeloma, monoclonal protein and finally drug treatment of plasma cell diseases are complex and not fully elucidated. Pulmonary hypertension has been reported as a rare complication of multiple myeloma (MM), more frequently in patients with POEMS syndrome. More recently pulmonary hypertension has been described during thalidomide treatment for refractory MM. We report a case of severe pulmonary hypertension associated with MM, pleural and cardiac amyloidosis. A revision of literature follows.
No takes yet. Share an insight, caveat, or question.
Carlo Rostagno (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: